台股 » 個股 » 神隆 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

神隆

(1789)
可現股當沖
  • 股價
    28.35
  • 漲跌
    ▼0.30
  • 漲幅
    -1.05%
  • 成交量
    1,105
  • 產業
    上市 生技醫療類股
  • 302人加入追蹤

    立即追蹤

  • 本地時間:13:30

     
神隆 (1789)籌碼相關-聯邦-富強 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

聯邦-富強 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2024/05/2300.00228.4528.35-21,478-0.14%
2024/05/21129.7500.0029.3511,4530.07%
2024/05/20229.00129.3529.3511,3870.07%
2024/05/17228.2000.0028.6021,3410.15%
2024/05/07128.7500.0028.2011,2880.08%
2024/05/0200.00128.6528.65-11,257-0.08%
2024/04/29129.1000.0029.1011,2280.08%
2024/04/1100.00128.0528.05-11,069-0.09%
2024/03/2900.00128.3027.65-1876-0.11%
2024/03/27226.4000.0026.6526990.29%
2024/02/2100.00125.4025.35-1608-0.16%
2024/02/1600.00125.5025.55-1614-0.16%
2024/02/05225.4300.0025.4026190.32%
2023/08/2500.00127.0026.90-13,100-0.03%
2023/07/20332.0000.0031.3032,6860.11%
2023/07/181734.171033.8033.7072,2130.32%
2023/05/2400.00126.5526.60-11,208-0.08%
2023/04/28128.60128.5528.4001,1540.00%
2023/03/0200.00126.6026.75-11,982-0.05%
2023/02/10126.0000.0025.8511,9600.05%
2022/12/1500.00225.5525.80-21,294-0.15%
2022/12/14826.10826.2526.0001,2770.00%
2022/12/131226.801027.3527.1521,2090.17%
2022/09/05128.85128.6528.3002,9580.00%
2022/08/22127.50127.0527.0502,2390.00%
2022/08/1600.00226.6026.55-22,019-0.10%
2022/08/03124.3500.0024.4511,9030.05%
2022/08/0200.00225.3024.90-21,889-0.11%
2022/07/28125.7000.0025.8011,8250.05%
2022/07/25427.11226.9827.1521,2570.16%
2022/07/2000.00125.6025.60-11,189-0.08%
2022/07/0700.00125.4524.70-11,984-0.05%
2022/06/2700.00125.5525.60-11,855-0.05%
2022/04/2600.00125.5524.85-11,310-0.08%
2022/04/25126.05226.0525.60-11,274-0.08%
2022/04/21427.41127.3027.4031,1390.26%
2022/04/1900.00126.1025.85-1745-0.13%
2022/04/18126.25226.6327.00-1604-0.17%
2022/04/15224.8000.0024.5524420.45%
2021/08/1800.00124.5024.45-11,463-0.07%
2021/07/13126.0000.0025.7512,6930.04%
2021/06/11128.10427.9527.45-32,873-0.10%
2021/06/08127.65227.4027.30-12,817-0.04%
2021/06/0700.00327.6527.40-32,817-0.11%
2021/06/04327.2000.0027.1032,7900.11%
2021/06/01127.00127.5527.5502,7420.00%
2021/05/31327.8000.0027.6032,7190.11%
2021/05/2800.00328.2028.50-32,621-0.11%
2021/05/2700.00527.2027.80-52,486-0.20%
2021/05/25325.9500.0025.6532,3600.13%
2021/05/1900.00626.5026.45-62,335-0.26%
2021/05/17226.9000.0026.6022,2850.09%
2021/05/14626.0000.0025.9062,1680.28%
2021/05/04328.0000.0028.0031,8090.17%
2021/05/0300.00629.2529.55-61,719-0.35%
2021/04/28329.1500.0028.6531,6120.19%
2021/04/20227.6500.0027.7021,2740.16%
2021/04/13226.9800.0026.8021,2550.16%
2021/04/09126.85127.2027.0001,1980.00%
2021/03/18125.2000.0025.2511,1130.09%
2021/01/13127.0000.0027.0011,0620.09%
2020/12/2900.00128.7528.65-11,009-0.10%
2020/12/02128.8500.0028.9511,5710.06%
2020/10/1600.00129.9029.75-12,470-0.04%
2020/09/2800.00130.0029.85-13,617-0.03%
2020/09/1000.00132.3532.10-16,641-0.02%
2020/09/08235.20135.1034.8017,5770.01%
2020/09/04133.00132.5032.5007,6040.00%
2020/09/0100.00133.0532.40-17,789-0.01%
2020/08/3100.00132.7032.90-17,805-0.01%
2020/08/28132.70232.7832.55-17,798-0.01%
2020/08/26132.45131.9032.7507,8300.00%
2020/08/2500.00131.7531.85-17,867-0.01%
2020/08/19133.40133.3033.3008,3600.00%
2020/08/18133.35133.5533.0508,4600.00%
2020/08/17132.90132.9033.2508,5660.00%
2020/08/101.833.3000.0033.051.88,8050.02%
2020/08/0700.00334.5034.10-38,895-0.03%
2020/08/06133.3000.0033.0518,9950.01%
2020/08/04132.6000.0032.4519,1070.01%
2020/07/28231.00130.4030.80110,1310.01%
2020/07/17133.30133.2032.75010,1380.00%
2020/07/15134.4500.0033.85110,1140.01%
2020/07/10136.7000.0035.25110,0810.01%
2020/07/09237.70237.6037.55010,0760.00%
2020/07/0800.00136.2036.60-19,893-0.01%
2020/07/07135.8500.0035.7019,7940.01%
2020/07/02238.6500.0037.9029,7140.02%
2020/07/0100.00138.0538.05-19,745-0.01%
2020/06/301138.801038.1037.7019,7170.01%
2020/06/29137.80137.5038.3009,4950.00%
2020/06/19239.80139.7039.1518,9050.01%
2020/06/1800.00438.8939.20-48,124-0.05%
2020/06/17235.78336.3035.65-17,612-0.01%
2020/06/16235.08335.3734.45-17,328-0.01%
2020/06/15735.15535.3634.8527,0840.03%
2020/06/12432.14432.2432.9006,4220.00%
2020/06/11231.6000.0031.4526,3560.03%
2020/06/10132.10132.3532.0006,3120.00%
2020/06/08231.63231.7531.3006,5710.00%
2020/05/29130.55130.4530.1007,9530.00%
2020/05/27131.20231.5030.90-17,937-0.01%
2020/05/26434.24234.1832.2527,8370.03%
2020/05/25232.68332.5332.90-17,510-0.01%
2020/05/19232.3000.0032.0527,3760.03%
2020/05/1800.00232.6532.30-27,298-0.03%
2020/05/15130.9000.0030.9017,1870.01%
2020/05/14132.6500.0031.5017,1720.01%
2020/05/1300.00133.0532.90-17,064-0.01%
2020/05/12131.6500.0031.6016,8520.01%
2020/05/06132.70133.3531.7006,5720.00%
2020/05/05333.27332.8532.1006,4160.00%
2020/04/2700.00630.0929.70-65,818-0.10%
2020/04/24129.5000.0028.8015,7390.02%
2020/04/23128.35128.6528.6005,7000.00%
2020/04/15129.70129.3028.9005,4810.00%
2020/04/14130.25130.7529.4005,4180.00%
2020/04/10129.15229.2329.00-15,181-0.02%
2020/04/09128.55228.5028.40-15,100-0.02%
2020/04/07228.25128.2028.0014,9690.02%
2020/04/06229.23229.3329.4004,8740.00%
2020/04/01126.45127.0027.0004,6960.00%
2020/03/25524.3000.0024.2054,3600.11%
2020/03/1600.00127.8527.00-13,999-0.03%
2020/03/13227.10527.7027.20-33,843-0.08%
2020/03/12130.05131.3030.1003,6950.00%
2020/03/11232.5300.0032.3023,4400.06%
2020/03/10434.3300.0033.7543,2040.12%
2020/03/0900.00237.1837.50-22,953-0.07%
2020/02/191428.401428.4228.3502,7980.00%
2020/02/1200.00127.9027.95-12,648-0.04%
2020/02/06129.0000.0027.8512,4960.04%
2020/02/0400.00125.8025.70-12,315-0.04%
2020/02/03124.9000.0024.9012,3040.04%
2020/01/3000.00127.5027.05-12,272-0.04%
2020/01/17127.0000.0026.9012,1710.05%
2020/01/1400.00126.6526.60-12,135-0.05%
2020/01/10127.1000.0026.8012,0890.05%
2020/01/08125.3500.0025.1012,0270.05%
2020/01/06126.1500.0026.0012,0120.05%
2019/11/2100.00128.3029.10-11,070-0.09%
2019/11/20326.98227.1828.0017490.13%
2019/06/2100.00125.0025.05-1340-0.29%
2019/03/19126.6500.0026.3015180.19%
2018/12/04127.60127.1527.1006530.00%
2018/08/2700.00131.5031.50-1536-0.19%
2018/08/22131.2000.0031.3515970.17%
2018/01/15536.00536.1536.7001,2970.00%
逸達前列腺癌新藥獲美藥證 神隆同步受惠Anue鉅亨-2021/05/27
〈神隆法說〉上游原物料漲幅過大 部分產品將啟動漲價Anue鉅亨-2021/05/26
〈神隆法說〉常熟廠代客研製新藥下半年放量 營運可望改善Anue鉅亨-2021/05/26
神隆 相關文章